Litcius/Paper detail

AP-1 signaling modulates cardiac fibroblast stress responses

Alexander J. Whitehead, Hamza Atcha, James D. Hocker, Bing Ren, Adam J. Engler

2023Journal of Cell Science15 citationsDOIOpen Access PDF

Abstract

Matrix remodeling outcomes largely dictate patient survival post myocardial infarction. Moreover, human-restricted noncoding regulatory elements have been shown to worsen fibrosis, but their mechanism of action remains elusive. Here, we demonstrate, using induced pluripotent stem cell-derived cardiac fibroblasts (iCFs), that inflammatory ligands abundant in the remodeling heart after infarction activate AP-1 transcription factor signaling pathways resulting in fibrotic responses. This observed signaling induces deposition of fibronectin matrix and is further capable of supporting immune cell adhesion; pathway inhibition blocks iCF matrix production and cell adhesion. Polymorphisms in the noncoding regulatory elements within the 9p21 locus (also referred to as ANRIL) redirect stress programs, and in iCFs, they transcriptionally silence the AP-1 inducible transcription factor GATA5. The presence of these polymorphisms modulate iCF matrix production and assembly and reduce cell-cell signaling. These data suggest that this signaling axis is a critical modulator of cardiac disease models and might be influenced by noncoding regulatory elements.

Topics & Concepts

BiologyTranscription factorCell biologyFibronectinSignal transductionCell adhesionCardiac fibrosisCellExtracellular matrixFibrosisCancer researchGeneticsGeneInternal medicineMedicineCardiac Fibrosis and RemodelingPeptidase Inhibition and AnalysisSignaling Pathways in Disease
AP-1 signaling modulates cardiac fibroblast stress responses | Litcius